title: A novel element in the management of chronic granulomatous disease (CGD)? - treatment of osteomyelitis with additional hyperbaric oxygen therapy (HBO).
abstract: Chronic granulomatous disease (CGD) is caused by malfunctioning of the phagocyte NADPH oxidase responsible for the generation of microbicidal reactive oxygen species. It is characterized by severe recurrent infections with catalase positive bacteria. Bacterial or fungal osteomyelitis is a common complication which often does not respond sufficiently to intravenous antibiotic treatment. We report the case of a four year old boy with CGD and osteomyelitis of the mandible refractory to intravenous antibiotic therapy. Introduction of hyperbaric oxygen therapy (HBO) was well tolerated and led to resolution of the osteomyelitis.
authors.affiliation: Children's Hospital, HELIOS Klinikum Krefeld, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Beltz
authors.forename: A
authors.initials: A
authors.lastname: Christaras
authors.forename: A
authors.initials: A
authors.lastname: Kovacevic
authors.forename: J
authors.initials: J
authors.lastname: Schaper
authors.forename: H
authors.initials: H
authors.lastname: Strelow
authors.forename: T
authors.initials: T
authors.lastname: Niehues
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D006105:Granulomatous Disease, Chronic / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D006931:Hyperbaric Oxygenation; D008279:Magnetic Resonance Imaging; D008334:Mandible / Q000473:pathology; D008336:Mandibular Diseases / Q000628:therapy*; D010019:Osteomyelitis / Q000175:diagnosis / Q000628:therapy*; D012008:Recurrence
chemical_list: D000900:Anti-Bacterial Agents